DK3142659T3 - Hiv-1 proteasehæmmere og anvendelser deraf - Google Patents
Hiv-1 proteasehæmmere og anvendelser deraf Download PDFInfo
- Publication number
- DK3142659T3 DK3142659T3 DK15792991.0T DK15792991T DK3142659T3 DK 3142659 T3 DK3142659 T3 DK 3142659T3 DK 15792991 T DK15792991 T DK 15792991T DK 3142659 T3 DK3142659 T3 DK 3142659T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461994462P | 2014-05-16 | 2014-05-16 | |
PCT/US2015/031181 WO2015175994A1 (en) | 2014-05-16 | 2015-05-15 | Hiv-1 protease inhibitors and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3142659T3 true DK3142659T3 (da) | 2021-05-31 |
Family
ID=54480812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15792991.0T DK3142659T3 (da) | 2014-05-16 | 2015-05-15 | Hiv-1 proteasehæmmere og anvendelser deraf |
Country Status (5)
Country | Link |
---|---|
US (1) | US9670225B2 (da) |
EP (1) | EP3142659B1 (da) |
JP (1) | JP6622290B2 (da) |
DK (1) | DK3142659T3 (da) |
WO (1) | WO2015175994A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9670225B2 (en) | 2014-05-16 | 2017-06-06 | Purdue Research Foundation | HIV-1 protease inhibitors and uses thereof |
WO2017031220A1 (en) * | 2015-08-17 | 2017-02-23 | Ghosh Arun K | Hiv-1 protease inhibitors and uses thereof |
JP7098643B2 (ja) * | 2016-11-09 | 2022-07-11 | パーデュー・リサーチ・ファウンデーション | Hiv/aidsに対する強力な三環式p2リガンド含有hivプロテアーゼ阻害剤 |
JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
WO2019006335A1 (en) * | 2017-06-30 | 2019-01-03 | Ghosh Arun K | INHIBITORS OF HIV-1 PROTEASE AND USES THEREOF |
TWI766172B (zh) | 2018-07-30 | 2022-06-01 | 美商基利科學股份有限公司 | 抗hiv化合物 |
EP3938371A4 (en) * | 2019-01-15 | 2023-01-18 | Purdue Research Foundation | HIV-1 PROTEASE INHIBITORS AND THEIR USES |
CA3171361A1 (en) * | 2020-03-18 | 2021-09-23 | Arun K. Ghosh | Tricyclic p2-ligand containing potent hiv-protease inhibitors |
US20230399338A1 (en) | 2022-06-10 | 2023-12-14 | Arun K. Ghosh | METHOD OF SYNTHESIZING (3S,3AR,5R,7AS,8S)- HEXAHYDRO-4H-3,5-METHANOFURO[2,3-b]PYRAN-8-OL |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2049547A2 (en) * | 2006-07-21 | 2009-04-22 | Gilead Sciences, Inc. | Aza-peptide protease inhibitors |
US20080070910A1 (en) * | 2006-07-24 | 2008-03-20 | Desai Manoj C | Therapeutic compounds and methods |
EP2304043A4 (en) * | 2008-07-09 | 2012-05-30 | Purdue Research Foundation | HIV PROTEASE INHIBITORS AND METHOD FOR THEIR USE |
JP6006211B2 (ja) * | 2010-09-02 | 2016-10-12 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | 3員環の縮合エーテルカルバメートおよびその使用 |
US9670225B2 (en) | 2014-05-16 | 2017-06-06 | Purdue Research Foundation | HIV-1 protease inhibitors and uses thereof |
-
2015
- 2015-05-15 US US15/311,806 patent/US9670225B2/en active Active
- 2015-05-15 DK DK15792991.0T patent/DK3142659T3/da active
- 2015-05-15 JP JP2017512877A patent/JP6622290B2/ja active Active
- 2015-05-15 WO PCT/US2015/031181 patent/WO2015175994A1/en active Application Filing
- 2015-05-15 EP EP15792991.0A patent/EP3142659B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3142659B1 (en) | 2021-03-24 |
US9670225B2 (en) | 2017-06-06 |
WO2015175994A1 (en) | 2015-11-19 |
JP2017515914A (ja) | 2017-06-15 |
EP3142659A1 (en) | 2017-03-22 |
JP6622290B2 (ja) | 2019-12-18 |
US20170088555A1 (en) | 2017-03-30 |
EP3142659A4 (en) | 2017-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
DK3205650T3 (da) | Egfr-hæmmer og fremstilling og anvendelse deraf | |
DK3521289T3 (da) | Mnk-inhibitorer og fremgangsmåder forbundet dermed | |
DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
DK3442972T3 (da) | Bromdomænehæmmere | |
DK3152607T3 (da) | En antiresonant hulkernefiber | |
DK3333191T3 (da) | Anti-C10ORF54-antistoffer og anvendelser deraf | |
DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
BR112016030697A2 (pt) | inibidores da desmetilase-1 específica da lisina | |
DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
DK3193611T3 (da) | Mk2-inhibitorer og anvendelser deraf | |
BR112017000042A2 (pt) | inibidores de desmetilase-1 lisina-específica | |
DK3230795T3 (da) | Prægelak og fremgangsmåde til prægning | |
DK3142659T3 (da) | Hiv-1 proteasehæmmere og anvendelser deraf | |
DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
DK3233105T3 (da) | Hidtil ukendt kombination og anvendelse |